Verified Panel · Family-Centered · IRB-Ready
Research conducted through and with families
Research into rare pediatric and genetic diseases is, almost without exception, research conducted through and with families rather than with patients alone. Parental consent, proxy reporting, sibling impact, and the particular emotional weight of a genetic diagnosis in a child all shape what good research design looks like in this category.
MedPanel applies verified panel recruitment and family-centered methodology to support sponsors working in this demanding but critically important therapeutic space.
Proxy report · Sibling impact · Whole-family
N. America · Europe · Asia-Pacific · LATAM
Child diagnosis & guardian relationship
Parental consent & child assent
Why This Therapeutic Area Requires Distinct Research Design
Three characteristics of pediatric rare genetic disease shape how research in this area must be designed, each extending beyond the patient to the family as a whole.
- Proxy reporting is the structural default. In pediatric rare disease research this is the norm rather than an exception requiring special justification. Parents and caregivers are the primary source of disease impact information for young children, and research instruments must be designed from the ground up for proxy response rather than adapted from adult self-report formats.
- Genetic diagnosis carries distinct psychological weight. It frequently involves parental guilt, family planning implications, and questions about recurrence risk for future children — dimensions of family experience that extend well beyond the immediate clinical picture and that research in this category should be prepared to explore when relevant to study objectives.
- Whole-family impact must be accounted for directly. Siblings of affected children frequently experience their own burden — caregiving responsibilities, reduced parental attention, and disruption to family routines — that is relevant to comprehensive disease burden characterization but often overlooked in research designed around the patient-caregiver dyad alone.
Research Approaches MedPanel Applies in This Therapeutic Area
MedPanel matches methodology to the specific research question, drawing on family-centered caregiver, diagnostic-odyssey, early-diagnosis, and treatment-decision research designs.
Caregiver and family research
Caregiver and family research is the foundation of MedPanel’s approach in this category. Our caregiver studies methodology is built specifically for parent and family proxy reporting, capturing the emotional, financial, physical, and time burden dimensions specific to raising a child with a rare genetic condition.
Diagnostic odyssey research
Diagnostic odyssey research captures the often extensive path families travel before reaching a definitive genetic diagnosis — relevant both for awareness campaign development and for understanding the cumulative burden of prolonged diagnostic uncertainty. MedPanel’s in-depth interview methodology supports the depth this narrative requires.
Newborn screening and early diagnosis research
Newborn screening and early diagnosis research is increasingly relevant as screening panels expand internationally for several conditions in this category, creating populations diagnosed presymptomatically whose family experience differs meaningfully from historically diagnosed cohorts. MedPanel’s observational and longitudinal research practice supports comparative studies across these distinct diagnostic pathways.
Treatment decision and clinical trial perception research
Treatment decision and clinical trial perception research helps sponsors understand how families evaluate participation in clinical trials, gene therapy programs, or expanded access pathways for their children — research that requires particular sensitivity given the stakes involved in pediatric treatment decisions. MedPanel’s focus group and survey methodologies support this work with age- and condition-appropriate design.
A Verified Panel Built for Family-Centered Recruitment
Pediatric genetic disease recruitment calls for a dual verification standard that self-reported panels are particularly poorly equipped to meet.
Recruitment in pediatric rare genetic disease research requires verification of both the child’s diagnosis and the legitimacy of the parent or guardian relationship — a dual verification standard that self-reported panels are particularly poorly equipped to meet. MedPanel’s verification protocol confirms diagnosis through physician attestation and medical record review, alongside appropriate confirmation of caregiving relationship and consent authority.
MedPanel’s global reach across North America, Europe, Asia-Pacific, and Latin America supports research into geographically dispersed pediatric rare disease populations, including conditions where newborn screening availability varies significantly by market — a variable directly relevant to study design and population characterization.
IRB Considerations Specific to Pediatric Research
Research involving minors carries distinct consent architecture requirements that MedPanel’s documentation is built to address from the outset.
Research involving minors carries distinct consent architecture requirements, and MedPanel’s IRB-ready documentation addresses the specific protocols this entails — parental consent alongside age-appropriate child assent where applicable, and additional safeguards reflecting the vulnerable population status of pediatric research participants.
Start your research
Start Your Rare Pediatric & Genetic Disease Research Program
From family-centered caregiver studies to diagnostic odyssey research, MedPanel’s verified panel and rare disease specialists bring the sensitivity and methodological rigor this population requires.
Panel feasibility confirmed for your target population
Methodology recommended for your study goals
Dual verification — child diagnosis & guardian relationship- IRB-ready documentation from day one
Contact MedPanel to discuss your research objectives in rare pediatric and genetic diseases. We will confirm panel feasibility and recommend a methodology suited to your study goals.